{"id":"https://openalex.org/W3134068415","doi":"https://doi.org/10.1080/21645515.2021.1882282","title":"Nigerian media coverage of medical progress on the development of COVID-19 vaccine","display_name":"Nigerian media coverage of medical progress on the development of COVID-19 vaccine","publication_year":2021,"publication_date":"2021-03-11","ids":{"openalex":"https://openalex.org/W3134068415","doi":"https://doi.org/10.1080/21645515.2021.1882282","mag":"3134068415","pmid":"https://pubmed.ncbi.nlm.nih.gov/33705258","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8475581"},"language":"en","primary_location":{"id":"doi:10.1080/21645515.2021.1882282","doi":"https://doi.org/10.1080/21645515.2021.1882282","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2021.1882282","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1882282?needAccess=true","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1882282?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038935705","display_name":"Chika Euphemia Asogwa","orcid":"https://orcid.org/0000-0003-1246-7014","observed_orcids":["https://orcid.org/0000-0003-1246-7014"]},"institutions":[{"id":"https://openalex.org/I43427933","display_name":"Federal University Oye Ekiti","ror":"https://ror.org/02q5h6807","country_code":"NG","type":"education","lineage":["https://openalex.org/I43427933"]}],"countries":["NG"],"is_corresponding":true,"raw_author_name":"Chika Euphemia Asogwa","raw_affiliation_strings":["Department of Mass Communication, Federal University, Oye-Ekiti, Nigeria"],"raw_orcid":"https://orcid.org/0000-0003-1246-7014","affiliations":[{"raw_affiliation_string":"Department of Mass Communication, Federal University, Oye-Ekiti, Nigeria","institution_ids":["https://openalex.org/I43427933"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5038935705"],"corresponding_institution_ids":["https://openalex.org/I43427933"],"apc_list":{"value":2895,"currency":"EUR","value_usd":3175},"apc_paid":null,"fwci":2.4498,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.89141757,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"17","issue":"8","first_page":"2421","last_page":"2426"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13979","display_name":"Communication and COVID-19 Impact","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T13979","display_name":"Communication and COVID-19 Impact","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10133","display_name":"News Media Framing and Political Communication","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14159","display_name":"Discourse Analysis and Cultural Communication","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3316","display_name":"Cultural Studies"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19-vaccine-development","display_name":"COVID-19 vaccine development","score":0.9629999995231628},{"id":"https://openalex.org/keywords/media-coverage","display_name":"media coverage","score":0.9449999928474426},{"id":"https://openalex.org/keywords/nigerian-media","display_name":"Nigerian media","score":0.8410000205039978},{"id":"https://openalex.org/keywords/news-sources","display_name":"news sources","score":0.48100000619888306},{"id":"https://openalex.org/keywords/newspapers","display_name":"newspapers","score":0.36500000953674316},{"id":"https://openalex.org/keywords/television-news","display_name":"television news","score":0.9800000190734863},{"id":"https://openalex.org/keywords/medical-communication","display_name":"medical communication","score":0.7580000162124634},{"id":"https://openalex.org/keywords/science-communication","display_name":"science communication","score":0.48100000619888306},{"id":"https://openalex.org/keywords/medical-journalism","display_name":"medical journalism","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C201280247","wikidata":"https://www.wikidata.org/wiki/Q11032","display_name":"Newspaper","level":2,"score":0.8240660429000854},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7194998264312744},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4887847602367401},{"id":"https://openalex.org/C162446236","wikidata":"https://www.wikidata.org/wiki/Q653137","display_name":"Content analysis","level":2,"score":0.4358171224594116},{"id":"https://openalex.org/C558299567","wikidata":"https://www.wikidata.org/wiki/Q11033","display_name":"Mass media","level":2,"score":0.4288289546966553},{"id":"https://openalex.org/C112698675","wikidata":"https://www.wikidata.org/wiki/Q37038","display_name":"Advertising","level":1,"score":0.4241277873516083},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.4121185839176178},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40943408012390137},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.34980013966560364},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.3359750509262085},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2847381830215454},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.22241714596748352},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.21777895092964172},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.12707200646400452},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08662652969360352},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003142","descriptor_name":"Communication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008402","descriptor_name":"Mass Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009549","descriptor_name":"Nigeria","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/21645515.2021.1882282","doi":"https://doi.org/10.1080/21645515.2021.1882282","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2021.1882282","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1882282?needAccess=true","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8475581","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8475581","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hum Vaccin Immunother","raw_type":"Text"},{"id":"pmid:33705258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33705258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human vaccines & immunotherapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:be164e4cfb7d4d509545937ff8ccf4ce","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/be164e4cfb7d4d509545937ff8ccf4ce","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2421-2426 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/21645515.2021.1882282","doi":"https://doi.org/10.1080/21645515.2021.1882282","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2021.1882282","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1882282?needAccess=true","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3134068415.pdf","grobid_xml":"https://content.openalex.org/works/W3134068415.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1964955643","https://openalex.org/W2019369783","https://openalex.org/W3001118548","https://openalex.org/W3003668884","https://openalex.org/W3006472059","https://openalex.org/W3008196127","https://openalex.org/W3012611856","https://openalex.org/W3047959706","https://openalex.org/W3094308667","https://openalex.org/W3102055527","https://openalex.org/W3102190406","https://openalex.org/W3103373858","https://openalex.org/W3106175163","https://openalex.org/W3106299621","https://openalex.org/W3114305588","https://openalex.org/W4243551552","https://openalex.org/W4301878612"],"related_works":["https://openalex.org/W3102190406","https://openalex.org/W7030681776","https://openalex.org/W7118375181","https://openalex.org/W6888445862","https://openalex.org/W4406132007","https://openalex.org/W7154912047","https://openalex.org/W3203126307","https://openalex.org/W7211919141","https://openalex.org/W4406969959","https://openalex.org/W4293236273"],"abstract_inverted_index":{"There":[0],"is":[1,29],"a":[2,44,109],"global":[3],"shift":[4],"in":[5,158],"discource":[6],"on":[7,24,43,132,168],"issues":[8,38],"related":[9,39,135],"to":[10,16,31,34,40,56,75,136],"COVID-19":[11,28,66,133],"with":[12,108],"greater":[13],"attention":[14,72],"paid":[15,74],"the":[17,22,47,52,76,97,113,121,129,142],"vaccine.":[18],"COVID-19.":[19],"Despite":[20],"this,":[21],"literature":[23],"media":[25,35,64,130],"coverage":[26,36],"of":[27,37,51,78,81,105,120,128,141,146,165],"yet":[30],"be":[32],"extended":[33],"medical":[41,169],"progress":[42],"vaccine":[45,67,137,159],"for":[46,96,115],"virus.":[48],"The":[49,100,118,163],"objective":[50],"current":[53,98,101,122],"study":[54,102,123],"was":[55,73],"fill":[57],"this":[58],"gap":[59],"by":[60],"examining":[61],"how":[62],"Nigerian":[63],"report":[65],"development":[68,160],"In":[69],"doing":[70],"so,":[71],"frequency":[77],"coverage,":[79],"sources":[80,148],"stories":[82,131,143],"as":[83,85,112,149,151],"well":[84,150],"story":[86],"type":[87],"used.":[88],"Two":[89],"newspapers":[90,155],"and":[91,171],"TV":[92],"stations":[93],"were":[94,134],"sampled":[95],"study.":[99],"made":[103,144],"use":[104,145],"content":[106],"analysis":[107],"code":[110],"sheet":[111],"instrument":[114],"data":[116],"collection.":[117],"result":[119],"revealed":[124],"that":[125],"only":[126],"23%":[127],"development.":[138],"Additionally,":[139],"most":[140],"official":[147],"straight":[152],"news.":[153],"Comparatively,":[154],"covered":[156],"more":[157],"than":[161],"TV.":[162],"implications":[164],"these":[166],"results":[167],"communication":[170],"theory":[172],"are":[173],"discussed.":[174]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-03-15T00:00:00"}